Screening and Treatment of Pediatric Dyslipidemias

Pediatric Versus Adult Management

The American College of Cardiology in conjunction with the American Heart Association released updated guidelines in November 2013 for treatment of hyperlipidemia in adults. These new guidelines eliminate LDL-C targets for monitoring therapy and identify four groups of adults as candidates for statin therapy:

• 
  Those with atherosclerotic CVD who require secondary prevention
  
• 
  Those with LDL-C ≥190 mg/dL without a secondary cause
  
• 
  Those aged 40 to 75 years with diabetes but no established CVD who have an LDL-C of 70 to 189 mg/dL
  
• 
  Those aged 40 to 75 years who do not have diabetes or atherosclerotic CVD but who have an LDL-C of 70 to 189 mg/dL with a calculated CVD risk of ≥7.5%.